- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02748720
Respiratory Dynamics During Birth Stabilization in Preterm Infants Less Than 32+6/7 Weeks Gestation
Impact of Measurement of Respiratory Dynamics During Birth Stabilization in Preterm Infants Less Than 32+6/7 Weeks Gestation
Study Overview
Detailed Description
HYPOTHESIS The ability to visualize the parameters and curves respiratory flow, tidal volume and air pressure by respiratory monitoring with MFR during cardiopulmonary resuscitation in newborns in the delivery room, decreases at least 10% surfactant need in first 72 hours of life.
EVALUATION Data collection will be made prospectively. Investigators will measure the parameters of lung mechanics (tidal volume expiratory airflow (TVe), peak inspiratory pressure (PIP), pressure at the end of exhalation (PEEP), inspiratory time (iT)), in each of inflations administered to preterm with VPP or during the administration of continuous positive airway pressure (CPAP) in spontaneous breathing, in the first 10 minutes after birth, recording the air leakage through the mask and obstructions. Investigators also measure parameters of respiratory status and hemodynamic (FIO 2, oxygen saturation, end tidal CO2, respiratory rate, heart rate), patient monitoring during the implementation of the protocol, blood gases, manipulations of the airway during intervention and the onset of complications.
Patients will be randomize in a Group 1, where these parameters of lung mechanics would be visible and other Group 2, where the parameters of TVe and respiratory flow would not be visible by the rescuer (the usual parameters of PIP and PEEP will be visible). Always, in both groups, current recommendations ventilation measures included in cardiopulmonary resuscitation of newborns of the Spanish Society of Neonatology, based on international recommendations (1-3.5) apply. In turn, the results analyzed in two subgroups between 24 and 27 + 6 weeks gestational age and 28 to 32 + 6 weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28009
- HGU Gregorio Marañon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- infants less than 32+6/7 weeks gestational age, birth requiring stabilization with VPP or CPAP in the delivery room.
Exclusion Criteria:
- Congenital Malformations or Chromosomal Aberrations
- Less Than 22 Weeks
- Birth-weight less Than the Third Percentile for Gestational Age According to Spanish Curve
- Severe Perinatal Asphyxia (Apgar Score of 0-3 More Than 5 Min, Cord Blood ph<7.00)
- reanimation unrecorded with video
- no obtained informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: RFM Visible
Patients will be randomize in other Group 1, where these parameters (from the device Respiratory Function Monitor) of lung mechanics would be visible by the rescuer (the usual parameters of PIP and PEEP will be visible).
We adapt or change PIP using visible TVe.
|
Will measure the expire tidal volume, end tidal CO2 and peak pressure changes according to clinical improvement and tidal volume
|
|
No Intervention: RFM No Visible
Patients will be randomize in a Group 2, where the parameters of TVe and respiratory flow would not be visible by the rescuer (the usual parameters of PIP and PEEP will be visible).
Always, in both groups, current recommendations ventilation measures included in cardiopulmonary resuscitation of newborns of the Spanish Society of Neonatology, based on international recommendations (1-3.5)
apply.
In turn, the results analyzed in two subgroups between 24 and 27 + 6 weeks gestational age and 28 to 32 + 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduce the need for surfactant.
Time Frame: through study completion, an average of 3 days
|
The aim of this study is to investigate whether the use of MFR during resuscitation of preterm (24-32 + 6 weeks) reduce the need for surfactant.
|
through study completion, an average of 3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Need for intubation and intermittent mechanical ventilation (iMV)
Time Frame: through study completion, an average of 3 days
|
Avoid intubation and Invasive Mechanical Ventilation in the next three days.
|
through study completion, an average of 3 days
|
|
Incidence of dysplasia bronchopulmonary
Time Frame: through study completion, an average of 1 year
|
Reduce incidence of dysplasia bronchopulmonary
|
through study completion, an average of 1 year
|
|
CPAP on admission to NICU
Time Frame: through study completion, an average of 1 day
|
Number of newborn with CPAP on admission to NICU
|
through study completion, an average of 1 day
|
|
Incidence of mortality
Time Frame: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
|
Measure and get desired tidal volume to optimize resuscitation
Time Frame: through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
|
Number of leaks and obstruction during ventilation mask
Time Frame: through study completion, an average of 1 day
|
The aim of this study is to investigate whether the use of MFR during resuscitation of preterm (24-32 + 6 weeks) reduce number of leaks and obstruction during mask ventilation and improves and set the desired tidal volume to optimize resuscitation.
|
through study completion, an average of 1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gonzalo Zeballos, MD, Gregorio Marañon hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Premature
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Chang Gung Memorial HospitalNot yet recruitingParent-Child Relations | Premature Infant Disease | Premature; Infant, Light-for-dates
-
The First Hospital of Jilin UniversityNot yet recruitingExtremely Premature Infant
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Istituto Giannina GasliniEubrainTerminated
Clinical Trials on RFM (device) Visible
-
University Hospital of North NorwayCompleted
-
The Alfred E. Mann Foundation for Scientific ResearchVA Office of Research and DevelopmentCompletedHemiparesisUnited States
-
Azienda Ospedaliera Universitaria Integrata VeronaSmith & Nephew Wound Management IncCompletedSurgical Site InfectionItaly
-
US Department of Veterans AffairsThe Alfred E. Mann Foundation for Scientific ResearchTerminatedStrokeUnited States
-
Brigham and Women's HospitalActive, not recruiting
-
University of AlbertaCompleted
-
University of BernCompletedExposure to Man-made Visible LightSwitzerland
-
Medical University of GrazCompleted
-
University of BernNot yet recruitingExposure to Man-made Visible LightSwitzerland
-
University of BernActive, not recruitingExposure to Man-made Visible LightSwitzerland